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2 Introduction  
To expand the knowledge on the identity of chemicals to which humans are exposed, the 
exploration of emerging chemicals is pursued within WP16 through complementary chemical and 
biological approaches. Suspect and non-target screening strategies using high resolution mass 
spectrometry (HRMS) will be implemented within the application of Effect-Directed Analysis (EDA) 
that uses a combination of (in vitro) bioassays, preparative fractionation and chemical analysis. In 
the context of tracking emerging substances, EDA may be used in a bottom-up approach entailed 
to first characterise the biological activity associated to particular fractions of a HBM sample then 
to guide the chemical identification work on this particular fraction to identify possible marker(s) of 
exposure responsible for this activity. These approaches aim to address the complex question of 
emerging substances using complementary angles respectively based on exposure assessment 
and hazard characterisation. Finally, their combination is expected to contribute to risk assessment 
and support to policy by providing data related both to real-world human exposure and to the 
potential toxicity of the considered substances. In addition, results from the work done in this 
WP16 task may serve as input for other WPs by providing candidates for further evaluation and 
eventual inclusion in future human biomonitoring campaigns. 
This deliverable focuses on effect-based approaches used in EDA, after providing background 
information related to the general definition, principle, and possible application/use of EDA. In 
addition, an inventory has been made to provide an overview of the main existing approaches in 
this field, further used as a support the selection of more particular toxicological endpoints of in 
vitro bioassays that will be implemented for hazard characterisation and prioritisation of human 
samples in the specific context of our HBM4EU project and its related WP16. 
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3 Background information 
3.1 Definition and principle 
Effect-based approaches to direct the chemical analysis and identification of Chemicals of 
Emerging Concern (CECs) have already been applied in various research fields including 
environmental sciences, pharmaceutical sciences and food safety (Jonker et al., 2015a; Groh and 
Muncke, 2017). At the present time, these approaches remain clearly less applied in the human 
biomonitoring area. 
In addition to suspect and non-target screening, EDA is one of the pillars in the identification of 
CECs in a wide variety of matrices. In the field of environmental sciences, the EDA concept has 
evolved in the course of the last two decades into a powerful tool to explore what bioactive 
chemicals are present in a sample. The application of in vitro bioassays inherently facilitates a 
prioritisation of samples, extracts or fractions to be studied for the presence of toxic CECs. 
In EDA, both chemistry based and biology based techniques are used in an iterative mode in order 
to identify the substances of interest, as shown in Figure 1.  
 
Figure 1. Schematic representation of EDA 
Basically, EDA comprises i) biological/toxicological testing to focus on active compounds, ii) 
fractionation to reduce the complexity of the sample to be tested and iii) identification and 
confirmation strategies using HRMS techniques and chemical/mass spectral databases for 
structural elucidation of the concerned substances. Recently, these building blocks of EDA were 
discussed in a comprehensive review focusing on the use of EDA as support for environmental 
quality monitoring of aquatic environments (Brack et al., 2016) as well as a demonstration program 
on the effect-based and chemical identification of toxic compounds in surface waters (Tousova et 
al., 2017). 
In any EDA study, the choice of endpoint and effect-based testing system intrinsically drives what 
type of chemicals will be identified. This choice then appears as a crucial issue especially in the 
context of looking for an extended range of emerging substances with various physico-chemical 
properties and subsequent various potential biological effects. A typical approach in EDA is to 
measure the biological activity is through, e.g. nuclear receptor binding (e.g. ER, AR, AhR)or the 
interaction with transport proteins (e.g. TTR-binding for thyroid hormone disruption).  
In this general context, this background section will first describe the main analytical and technical 
aspects related to EDA and will secondly summarise its current application in environmental, food 
and human matrices respectively. 
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3.2 Advancements in analytical chemistry 
To allow the identification of a broad range of bioactive compounds with diverse physico-chemical 
characteristics it is first necessary to use non-discriminating, non-destructive sample extraction and 
clean-up procedures. However, this non selective ambition is facing a practical limitation 
considering the non-compatibility of the detection systems with too complex biological samples. To 
address this complexity issue, high resolution fractionation approaches have been reported both 
based on liquid chromatography (LC) (Booij et al., 2014; Jonker et al., 2015b) and gas 
chromatography (GC) (Pieke et al., 2013; Jonker et al., 2017). To further increase the 
chromatographic separation resolution, comprehensive two-dimensional LCxLC can be used for 
specific applications to very complex extracts [Ouyang et al., 2016]. To obtain less complex, small 
volume fractions multi-well plates (96, 384, 1536) may be used in combination with miniaturised in 
vitro bioassays. Identification is facilitated by the correlation between bioassay response of 
fractions that contain only a few chemical peaks/signals and the accurate masses obtained by 
HRMS. 
The suitability of EDA for the identification of CECs has significantly improved by the 
advancements in the field of mass spectrometry and the availability of HRMS equipment. In 
addition, chemical (e.g.,  ChemSpider or PubChem) and mass spectral database development 
(e.g., Exposome Explorer, Neveu et al., 2017) in combination with freely available software tools 
and those from MS instrument manufacturers have aided the development of strategies for 
suspect screening and identification of unknowns. For the identification of environmental toxicants 
(Krauss et al., 2010; Weiss et al., 2011), scientists relied on the progress that was made towards 
identification of unknowns in the field of metabolomics (Kind and Fiehn, 2007; Draper et al., 2009). 
Although the identification success rate has increased as a result of the developments in the field 
of HRMS, identification is still a difficult task. Indeed, this significant challenge of identification 
imposes to mobilise multidisciplinary competences including advanced mass spectrometry and 
bioinformatics/data processing related expertise and resources. These necessary competences 
are present and will be used within WP16 (through dedicated actions defined in the 2nd AWP) with 
regard to (1) structural elucidation of not yet known chemical structures from MS and MS/MS data 
and (2) implementation of consolidated MS reference libraries for suspect screening of already 
known markers of exposure.   
3.3 Application of EDA on environmental samples 
So far, EDA studies were mainly applied to abiotic compartments of the environment such as water 
and sediment. In biological matrices, however, only a few applications of EDA have been 
described as reviewed by Simon et al., 2015. 
In the aquatic environment, the development and implementation of EDA strategies for 
investigative monitoring has been explored in the last decade, partly fuelled by European 
legislation (e.g. the Water Framework Directive). Within NORMAN, the Network of reference 
laboratories, research centres and related organisations for monitoring of emerging environmental 
substances, joint activities to promote the development and implementation of EDA, bioassays and 
nontarget screening in the indoor and outdoor environment have resulted in the advancement of 
the EDA strategies (Houtman et al., 2006; Weiss et al, 2011; Schmitt et al., 2012; Booij et al., 
2014; Muz et al., 2017). The bioassays used have primarily been reporter gene assays for the 
AhR, ER, or AR, binding assays for transthyrethin (TTR), or for genotoxicity. While in these abiotic 
environmental compartments contaminants are often predominant in the detectable compound 
inventory, the presence of the “endogenous metabolome” hampers detection of contaminants.  
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Other specific challenges related to samples of biological origin (including food and human 
samples) are the presence of endogenous hormones that may influence the readout of bioassays 
aiming at endocrine activity, the presence of highly abundant matrix constituents affecting bioassay 
performance (e.g. lipids) and the high sensitivity necessary for the chemical analysis due to the 
usually low levels of bioactive chemicals. Regarding the identification, the possibility of the 
presence of not only parent compounds, but certainly also metabolites, also appears as a major 
issue to take into account. A successful EDA study focusing on thyroid hormone disruptive 
compounds in polar bear plasma has been reported by Simon et al. (2013), who identified linear 
and branched nonylphenol and mono- and dihydroxylated octachlorinated biphenyls. 
3.4 Application of EDA on food and food packaging materials 
Employing classical approaches such as targeted analysis to characterise the chemical 
composition of food contact materials (FCMs) and successively testing single compounds for 
biological activities is inadequate, as it will neither provide any information on compounds that are 
not explicitly known to be present in the material, nor account for the total, integrated biological 
activities of all the compounds present in the product (i.e. ‘the cocktail effect’). To address these 
shortcomings, an EDA strategy can be applied, as has been exemplified in previous studies based 
on in vitro tests for genotoxicity (such as Ames test, p53 activation), cytotoxicity, and/or endocrine 
activity (such as ER, AR, AhR, PPARα/γ activity) in combination with advanced analytical 
chemistry to identify CEC in FCMs (Groh and Muncke, 2017; Rosenmai et al., 2017) 
3.5 Application of EDA on human samples 
EDA as a combination of bioassays, fractionation and chemical analysis has to our knowledge very 
rarely been used for identifying human samples. It has been applied for identifying androgens in 
human urine samples using an androgen receptor (AR) reporter gene assay with the purpose of 
using the assay in doping control (see study 14 and 15 in Table 1).  
However, bioassays have been applied on human samples to identify correlations between 
bioassay activities and exposure to persistent organic pollutants (POPs) or human health 
endpoints without identifying the chemicals that gave rise to the activity. In this way, the bioassay 
readout has served as a biomarker for effect and/or exposure. 
The application of EDA to human samples such as blood, urine, amniotic fluid, milk, or meconium, 
has great potential, as it may provide insight into which chemicals are found in the human body 
(i.e. the internal exposome) that we have not paid attention to so far. This knowledge is expected 
to support the mechanistic understanding of adverse effects through the selection of appropriate 
endpoints and appropriate in vitro bioassays to measure them (Escher et al., 2017).  
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4 Inventory of existing bioassay analyses of human samples 
In this section, an inventory of suitable and existing in vitro bioassays is first described, from which 
a selection will be made for further EDA work in human samples in the specific framework of the 
HBM4EU project and its related WP16. This inventory is given in Table 1 and includes 23 studies, 
where a single or a combination of a few bioassays has been used to study associations with 
either POP exposure or with human health endpoints such as male reproductive diseases or 
breast cancer. 
The majority of the studies  have been performed by a Danish (n = 12) and a Spanish (n = 12) 
research group from Aarhus University (no. 6-8,11-12, 27, 29,31-35) and Granada University (no. 
13-23 and 28), respectively. Four studies (no. 1-3,15) have been performed by people from the Bio 
Detection Systems company, the Netherlands, whereas the remaining studies originate from 
different research groups.  
4.1 Bioassays used so far 
Most focus so far has been on detection of arylhydrocarbon receptor (AhR) activity using reporter 
gene assays in human samples such as blood, follicular fluid, or milk from populations in Europe or 
Greenland. Indeed, a large set of lipophilic persistent organic pollutants (POPs) present the ability 
to bind AhR through their partially common mode of action at molecular level. Consequently, 
bioassays based on this particular receptor are relevant in screening for this large group of 
compounds. In many cases the bioassay activity has been compared with the total TCDD-
equivalents (TEQs) of PCBs and dioxins based on quantification by chemical analysis. The 
advantage of using the AhR assay is that any interference by endogenous hormones is not 
occurring with this assay. 
In other studies, estrogenic activity as measured by activation of the estrogen receptor (ER) using 
reporter gene assays or MCF7 proliferation has been determined, but in all cases human breast 
cancer cells have been the fundamental part of the assay. This estrogenic potency measurement 
is particularly employed for instance for screening endocrine disrupting chemicals. 
Androgenic activity has been also measured using reporter gene assays based on either CHO 
cells, U2OS cells or yeast cells with a read out reflecting either agonism or antagonism of the 
receptor. 
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5 Selected approaches 
5.1 Arylhydrocarbon Receptor bioassay  
In front of the very wide range of possible “emerging chemicals” to be addressed in the frame of 
the HBM4EU project and its related WP16, a priority action was focused on halogenated chemicals 
in their global screening for CEC in human samples. Indeed, this large category of compounds 
may encompass a large range of exposure markers (e.g. not yet known/addressed novel BFRs, 
phthalates, bromo-/chlorophenols, chlorinated paraffins…, including parent compounds and their 
transformation products). Moreover, these halogenated compounds exhibit typical isotopic pattern 
possibly used as a filter for extracting potential signals of interest from untargeted mass 
spectrometric profiles. 
As many halogenated chemicals are known to activate the AhR and as this bioassay is one of the 
most thoroughly tested bioassay on human samples, we will logically select this assay for a first 
round of measuring bioactivity. Methodologies for extraction of POPs and for running the bioassay 
are well-established. The intention is to identify one or more CECs with AhR activity. AhR activity is 
of increasing importance as this receptor is not only involved in liver metabolism and reproductive 
toxicity but also in the function of the immune system as well as in stem cell differentiation in the 
bone marrow. 
5.2 Transthyretin binding assay 
Thyroid hormone disruption can be effected through a variety of pathways, e.g. interference with 
the metabolism of thyroid hormones, their excretion or their transport through the body. Thyroid 
hormones are only sparingly soluble in blood plasma, through which thyroid hormones reach the 
location in the body where they have their effect. For this transport, several proteins are present in 
vertebrates, e.g. albumin, thyroxine-binding globulin (TBG) and transthyretin (TTR). Although not 
the most dominant transport protein, TTR is of importance because of its capacity to transport T4, 
but also xenobiotics, across the placenta and the blood-brain-barrier (Meerts et al., 2002).  A 
recent overview of compounds having the potential to disrupt the thyroid hormone system was 
given by Weiss et al., 2015, in which also the various assays that employ binding to TTR are listed. 
Historically, the interference of environmental pollutants with the thyroid hormone system is 
assessed by the competition with the radiolabelled endogenous hormone T4 in the binding to TTR.  
Using this assay, thyroid hormone disruption has been studied in-depth in polar bears (e.g. 
Bytingsvik et al., 2013) including an EDA study in polar bear plasma, revealing several highly 
metabolised (by hydroxylation) hepta- and octachlorinated biphenyls (Simon et al., 2011 and 
2013). Although very reliable, this laborious and rather costly T4*-TTR radioligand binding assay 
was not capable of sufficiently high throughput for effective application in EDA. Recently, a 
modification of the assay into an assay that utilises fluorescence was reported (Ren and Guo, 
2012), further adapted for high throughput EDA in 96 well plate format by Ouyang et al., 2017. 
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Table 1: Overview of existing Effect-Directed Analysis (EDA) approaches 
No Activity Bioassay used Sample preparation in brief Human population or 
cohorte 
Observed associations Reference 
1 AhR activity DR-CALUX from 
BDS (rat H4IIE 
hepatoma cell line) 
Total fat from 1 mL plasma extracted in 
97% hexane/ 3% diethyl ether. Passed 
through two acid silica columns topped 
first 20% and then 30% H2SO4 to 
remove matrix components. Evaporated 
under nitrogen and re-dissolved in 8μL 
of DMSO 
Maternal blood samples 
(“Rhea” mother–child 
cohort study in Crete and 
the Hospital del Mar cohort 
in Barcelona) 
Plasma dioxin-like activity was 
negatively associated with anogenital 
distance (AGD) in male newborns. The 
estimated change in AGD per 10 pg 
CALUX®–toxic equivalent/g lipid 
increase was –0.44 mm (95% CI: –
0.80, –0.08) after adjusting for 
confounders 
Vafeiadi et al. 
2013 
2  DR-CALUX from 
BDS (rat H4IIE 
hepatoma cell line) 
-do- -do- Dioxin-like activity in maternal blood 
was higher in the children born by 
mothers in the upper tertile of the “high-
fat diet” score during pregnancy, 
compared to the lower and middle 
tertiles and were positively correlated 
(Spearman's rho = 0.49, P b 0.001) 
Papadopoulou 
et al.2013 
3  AhR CALUX from 
BDS (rat H4IIE 
hepatoma cell line) 
n-hexane extraction of blood serum or 
follicular fluid aliquots (1-1.5 mL) and 
removal of acid labile matrix 
components 
106 serum and 9 follicular 
fluid samples collected 
from infertile women 
TEQ values in human extracts 
correlated well with the sum of four 
major PCB congeners (153, 138, 180, 
118) chemically determined in both 
serum and follicular fluid 
Pauwels et al. 
2000 
4  AhR CALUX from 
BDS (rat H4IIE 
hepatoma cell line) 
The fat in the milk samples was 
extracted by addition of sodium oxalate 
and ethanol to the milk and subsequent 
extractions with diethylether and n-
pentane, respectively. Clean-up on a 
silica column. 
16 Danish human milk 
samples 
TEQ levels in the total extract of the 16 
human milk samples were correlated to 
the TEQ levels determined by GC/MS 
(R= 0.73). Most samples gave higher 
TEQs with the CALUX assay. 
 
Laier et al. 
2003 
5  AhR CALUX from 
BDS (rat H4IIE 
hepatoma cell line) 
2 ml blood was extracted by n-hexane 
and passaged through a silica column. 
DMSO (7.5 μL) was added, and the 
extract was diluted to a total volume of 
750 μL with minimal essential medium. 
101 men 20–40 years of 
age were evaluated on 
sperm parameters, sex 
hormone levels and 
lifestyle factors 
Age and the frequency of fish and egg 
consumption were independent positive 
determinants of serum AhR activity. 
Two-fold increase in CALUX-TEQ was 
associated with a decreased 
testosterone, a pronounced drop in 
semen volume but increased sperm 
concentration. 
Dhooge et al, 
2006 
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No Activity Bioassay used Sample preparation in brief Human population or 
cohorte 
Observed associations Reference 
6  AhR assay from 
Denison (mouse 
Hepa1.12cr 
hepatoma cell line) 
POPs were extracted at Le Centre de 
Toxicologie, Sainte Foy, Quebec, CA, 
using ethanol and hexane, followed by 
cleaning on FlorisilCNa2SO4 column 
using 2 ml serum 
338 males from Greenland 
(Inuit's), Sweden, Poland 
and Ukraine 
The variation of AhR serum activity 
may reflect different pattern of POP 
exposure, genetics and/or life style 
factors. No consistent correlations 
between AhR activities and two POP 
markers were found. 
Long et al. 
2006 
7  AhR assay from 
Denison (mouse 
Hepa1.12cr 
hepatoma cell line) 
POPs were extracted at Le Centre de 
Toxicologie, Sainte Foy, Quebec, CA, 
using ethanol and hexane, followed by 
cleaning on FlorisilCNa2SO4 column 
using 2 ml serum 
357 serum samples from 
Greenland (South West 
Coast, North Coast and 
East Coast) 
85% of the Inuit samples elicited 
agonistic AhR transactivity in a district 
dependent pattern. The AhR 
transactivity was inversely correlated to 
the levels of sum POPs, age and/or 
intake of marine food 
Long et al. 
2007 
8  AhR assay from 
Denison (mouse 
Hepa1.12cr 
hepatoma cell line) 
POPs were extracted at Le Centre de 
Toxicologie, Sainte Foy, Quebec, CA, 
using ethanol and hexane, followed by 
cleaning on FlorisilCNa2SO4 column 
using 2 ml serum 
70 inhabitants  from 6 
different Greenlandic 
districts and young Danish 
volunteers 
The AhR-TEQs of the Inuits were 
significantly higher than that of the 
Danes. AhR-TEQ of Inuit were 
positively associated with plasma 
POPs after adjustment for age and/or 
the ratio of n-3 to n-6 fatty acids, 
whereas no  correlations were found for 
the Danish samples 
Bonefeld-
Jørgensen and 
Long, 2010 
9  AhR CALUX from 
XDS (mouse 
H1L6.1c3 
hepatoma cell line 
stably 
transfected with the 
pGudLuc6.1 
reporter) 
0.5 ml whole blood was extracted with 
0.5 ml tert-butyl methyl ether and 
resuspended in 200 ml hexane and this 
stock extract was used for creating 
dilutions to be analysed in the bioassay. 
10 human blood samples 
from volunteers under 
different dietary regimens 
Close to 1,000-fold higher TEQ values 
were found by using the bioassay 
compared to analytical chemistry, 
suggesting that human blood contains 
a relatively high level of AHR agonists 
apart from PCBs/dioxins /furans. A 
vegetarian diet increased AhR activity. 
Connor et al. 
2008 
10  AhR CALUX from 
XDS (mouse 
H1L6.1c3 
hepatoma cell line 
stably 
transfected with the 
pGudLuc6.1 
reporter) 
10 g human plasma was mixed with 30 
mL of acetone followed by extraction 
with 10 mL n-hexane. The concentrated 
extract (5 ml) was processed through an 
acid silica column in series with an 
activated carbon column. Dioxins were 
eluted and resuspended in 1.2 mL of n-
hexane. 
496 blood samples were 
collected for GC-HRMS 
and CALUX analyses 
A significant correlation was 
established between the bioassay and 
chemical method for 17 PCDD/F 
congeners (R = 0.64) 
Van Wouwe et 
al. 2004 
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No Activity Bioassay used Sample preparation in brief Human population or 
cohorte 
Observed associations Reference 
11 ER activity MVLN assay 
(stably transfected 
human breast 
cancer cells 
expressing ERα 
and ERβ) 
3.6 ml serum was extracted by SPE on 
an OASIS HLB column followed by 
HPLC fractionation on a Spherisorb 
Si60 normal phase column. The first 
fraction included most POPs while 
leaving out endogenous hormones 
358 men: Greenlandic 
Inuit's, Swedish fishermen, 
and inhabitants from 
Poland and Ukraine. 
No ER agonistic activity was found in 
Inuits, while 12 – 24% of the European 
samples had detectable ER activity. On 
the contrary, 71% of Inuit serum 
samples antagonised ER compared to 
7 – 30 % in the other regions. 
Jørgensen et 
al. 2006 
12  MVLN assay 
(stably transfected 
human breast 
cancer cells 
expressing ERα 
and ERβ) 
3 ml serum was extracted by SPE on an 
OASIS HLB column followed by HPLC 
fractionation on a Spherisorb Si60 
normal phase column. The F3 fraction 
included the PFAS. Estriol and Estetrol 
hormones were removed by weak anion 
exchange.  
397 pregnant women from 
Aarhus Birth Cohort 
52% of the PFAS serum extracts 
activated ER, and 46% enhanced the 
E2-induced ER transactivation. Positive 
linear concentration-response 
associations were found between the 
PFAS serum levels and the ER 
transactivation. 
Bjerregaard-
Olesen et al. 
2016 
13  MCF7 proliferation 
(human breast 
cancer cells) 
200 mg adipose tissue was dissolved in 
hexane and eluted in a glass column 
filled with Alumine Merck 90 (70–230 
mesh) no. 1097. The eluate was further 
purified by preparative HPLC on a 
Spheri 5 normal phase silica column. 
The first HPLC fraction α contained 
most of the POPs whereas the 
endogenous hormones were included in 
fraction β. 
400 women with various 
diseases undergoing 
surgical treatment at 
Granada University 
Hospitals and Almeria 
Hospital, Spain 
65% of the α-fractions and 76% of the 
β-fractions showed measurable 
estrogenicity. The mean estradiol 
equivalent (EEQ) unit was 750 pM 
EEQ/g lipid in the α-fraction and 903 
pM EEQ/g lipid in the β-fraction. 
Rivas et al. 
2001 
14  MCF7 proliferation 
(human breast 
cancer cells) 
200-500 mg adipose tissue was 
dissolved in hexane and eluted in a 
glass column filled with Alumine Merck 
90 (70–230 mesh) no. 1097. The eluate 
was further purified by preparative 
HPLC on a Spheri 5 normal phase silica 
column. The first HPLC fraction α 
contained most of the POPs whereas 
the endogenous hormones were 
included in fraction β. 
458 women with various 
diseases undergoing 
surgical treatment at 
Granada University 
Hospitals and Almeria 
Hospital, Spain 
75% of the α-fractions and 82% of the 
β-fractions showed measurable 
estrogenicity. The mean estradiol 
equivalent (EEQ) unit was 515 pM 
EEQ/g lipid in the α-fraction and 697 
pM EEQ/g lipid in the β-fraction. 
Fernandez et 
al. 2004 
15  MCF7 proliferation 
(human breast 
cancer cells) 
200 mg adipose tissue (breast tissue 
from cases; abdominal tissue from 
controls) was dissolved in hexane and 
eluted in a glass column filled with 
Alumine Merck 90 (70–230 mesh) no. 
198 breast cancer cases 
and 260 age and hospital 
matched controls 
undergoing non-cancer-
related surgery. Cases and 
Overall, the cancer risk was not 
associated with the total effective 
xenoestrogen burden (TEXB) in the α-
fraction. However, among cases with a 
body mass index (BMI) below the 
Ibarluzea et al. 
2004 
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1097. The eluate was further purified by 
preparative HPLC on a Spheri 5 normal 
phase silica column. The first HPLC 
fraction α contained most of the POPs 
whereas the endogenous hormones 
were included in fraction β. 
controls were recruited at 
the three largest public 
hospitals serving Granada 
and Almeria provinces in 
Spain. 
median (28.6 kg/m2), the odds ratio 
(OR) was 2.44 (95% CI 1.22–9.58) for 
women in the highest quartile of TEXB 
in the α-fraction versus those in the 
lowest. After including the TEXB of the 
β-fraction in the logistic regression 
model, the OR increased to 3.42 (95% 
CI 1.22–9.58) for those in the highest 
tertile versus those in the lowest. 
16  MCF7 proliferation 
(human breast 
cancer cells) 
1.6 g placenta homogenate was 
dissolved in hexane and eluted in a 
glass column filled with Alumine Merck 
90 (70–230 mesh) no. 1097. The eluate 
was further purified by preparative 
HPLC on a Spheri 5 normal phase silica 
column. The first HPLC fraction α 
contained most of the POPs whereas 
the endogenous hormones were 
included in fraction β. 
50 male newborn cases 
with congenital 
malformations and 114 
male newborn controls 
matched by gestational 
age, date of birth, and 
parity. Cases and controls 
were registered at the San 
Cecilio University Hospital, 
Granada, Spain 
The total effective xenoestrogen 
burden (TEXB) from the α-fraction was 
detectable in 72% and 54% of case 
and control placentas, respectively. 
Cases had an OR for detectable versus 
non-detectable TEXB of 2.82 (95% CI, 
1.10–7.24) compared with controls. 
Fernandez et 
al. 2007 
17  MCF7 proliferation 
(human breast 
cancer cells) 
1.6 g placenta homogenate was 
dissolved in hexane and eluted in a 
glass column filled with Alumine Merck 
90 (70–230 mesh) no. 1097. The eluate 
was further purified by preparative 
HPLC on a Spheri 5 normal phase silica 
column. The first HPLC fraction α 
contained most of the POPs whereas 
the endogenous hormones were 
included in fraction β. 
489 newborns from four 
cohorts in the Spanish 
Children's Health and 
Environment (INMA) study. 
For the tertile with the highest total 
effective xenoestrogen burden in the α-
fraction (TEXB-α), higher TEXB-α was 
associated with increased birthweight 
for boys (β=148.2 g, 95% CI: 14.01, 
282.53) but not for girls. 
Vilahur et al. 
2013 
18  MCF7 proliferation 
(human breast 
cancer cells) 
200 mg adipose tissue was dissolved in 
hexane and eluted in a glass column 
filled with Alumine Merck 90 (70–230 
mesh) no. 1097. No HPLC fractionation 
was performed in this study. 
386 study participants were 
recruited among patients 
undergoing non-cancer-
related surgery. 34 of the 
included participants 
suffered from type 2 
diabetes. 
The total effective xenoestrogen 
burden (TEXB) was not associated with 
type-2-diabetes. 
Arrebola et al. 
2013 
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19  MCF7 proliferation 
(human breast 
cancer cells) 
1.6 g placenta homogenate was 
dissolved in hexane and eluted in a 
glass column filled with Alumine Merck 
90 (70–230 mesh) no. 1097. The eluate 
was further purified by preparative 
HPLC on a Spheri 5 normal phase silica 
column. The first HPLC fraction α 
contained most of the POPs whereas 
the endogenous hormones were 
included in fraction β. 
489 children from four 
cohorts in the Spanish 
Children's Health and 
Environment (INMA) study. 
Overall, no association was found 
between the total effective 
xenoestrogen burden in the α-fraction 
(TEXB-α) and the mental scores at 1-2 
years of age. However, in tests of 
motor development at 1-2 years of age, 
boys in the third tertile of exposure 
scored on average 5.2 points less 
compared to those in the first tertile 
(p=0.052). The association 
disappeared at 4-5 years of age. 
Vilahur et al. 
2014a 
20  MCF7 proliferation 
(human breast 
cancer cells) 
1.6 g placenta homogenate was 
dissolved in hexane and eluted in a 
glass column filled with Alumine Merck 
90 (70–230 mesh) no. 1097. The eluate 
was further purified by preparative 
HPLC on a Spheri 5 normal phase silica 
column. The first HPLC fraction α 
contained most of the POPs whereas 
the endogenous hormones were 
included in fraction β. 
97 male and 95 female 
newborns from four cohorts 
in the Spanish Children's 
Health and Environment 
(INMA) study. 
Boys in the highest tertile of total 
effective xenoestrogen burden in the α-
fraction (TEXB- α) presented on 
average a decrease of 0.84% in 
AluYb8 DNA-methylation compared to 
those in the first tertile (p < 0.001), 
while no significant effects were found 
in girls (p = 0.134). 
Vilahur et al. 
2014b 
21  MCF7 proliferation 
(human breast 
cancer cells) 
1.6 g placenta homogenate was 
dissolved in hexane and eluted in a 
glass column filled with Alumine Merck 
90 (70–230 mesh) no. 1097. The eluate 
was further purified by preparative 
HPLC on a Spheri 5 normal phase silica 
column. The first HPLC fraction α 
contained most of the POPs whereas 
the endogenous hormones were 
included in fraction β. 
Discovery study: 181 
mother-child dyads. 
Replication study: 126 
mother-boy dyads. 
The dyads were included 
from four cohorts in the 
Spanish Children's Health 
and Environment (INMA) 
study. 
No genome-wide significant 
associations were found between the 
total effective xenoestrogen burden in 
the α-fraction (TEXB-α) and DNA 
methylation in either study group.  
Vilahur et al. 
2016 
22  MCF7 proliferation 
(human breast 
cancer cells) 
3 mL serum was extracted with 
hexane:ethyl ether (1:1). The organic 
phases were passed through a Bond 
Elut PCB cartridge. The eluate was 
further purified by preparative HPLC on 
a Spheri 5 normal phase silica column. 
The first HPLC fraction α contained 
most of the POPs whereas the 
186 breast cancer cases 
and 196 frequency-
matched controls were 
included from MCC-Spain, 
which is a population-
based multicase-control 
study. 
Cases had higher geometric mean total 
effective xenoestrogen burden in the α-
fraction (TEXB-α) and the β-fraction 
(TEXB-β) than controls. The fully 
adjusted odds ratios (OR) for breast 
cancer comparing the second and third 
tertiles of TEXB-α with the first tertile 
Pastor-Barriuso 
et al. 2016 
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endogenous hormones were included in 
fraction β. 
were 1.77 (95%CI: 0.76, 4.10) and 3.45 
(95%CI: 1.50, 7.97), respectively. 
For TEXB-β the ORs were 2.35 (1.10, 
5.03) and 4.01 (1.88, 8.56), 
respectively. 
23  MCF7 proliferation 
(human breast 
cancer cells) 
200 mg adipose tissue was dissolved in 
hexane and eluted in a glass column 
filled with Alumine Merck 90 (70–230 
mesh) no. 1097. The eluate was further 
purified by preparative HPLC on a 
Spheri 5 normal phase silica column. 
The first HPLC fraction α contained 
most of the POPs whereas the 
endogenous hormones were included in 
fraction β. 
55 women newly 
diagnosed with breast 
cancer and scheduled for 
surgery at San Cecilio 
University Hospital, 
Granada, Spain  
Breast adipose tissue was 
collected at the time of 
surgery and abdominal 
adipose tissue was 
collected at four time points 
after surgery (<6 months; 
12 months, 12-18 months, 
and >18 months). 
The total effective xenoestrogen 
burden in both the α-fraction (TEXB-α) 
and the β-fraction (TEXB-β) increased 
during the first 6-12 months after 
surgery, and then decreased lightly 
over time.  
Fernandez et 
al. 2017 
24  MCF7 prolifera-tion 
assay (human 
breast cancer cells) 
4 mL serum was extracted with an 
OASIS HLB 6 cc 500 mg extraction 
cartridge. Slow elution by 3 mL of 
methanol followed by 2 mL ethyl 
acetate. The aqueous phase was 
extracted 3 x by 1 mL n-heptane/ethyl 
acetate (1:1). Supernatants were 
reconstituted in 125 μL n-heptane /ethyl 
acetate (9:1).  
30 pregnant and 60 non-
pregnant Danish women 
plus 211 serum samples 
from pregnant Faroese 
women 
The estrogenicity of the serum from 
Danish controls exceeded the 
background in 22.7 % of the cases, 
while the same was true for 68.1 % of 
the Faroese samples. 
Rasmussen et 
al. 2003 
25 AR activity 
(agonism) 
Yeast androgen 
assay expressing 
human androgen 
receptor and β-
galactosidase 
Reverse phase LC dual 96-well fraction 
collection set-up followed by offline 
LC/QTOFMS/MS and bioactivity 
screening 
Human male and female 
urine samples by healthy 
volunteers from the 
laboratory 
These androgens were identified: 
Testosterone, 5α-dihydro-testosterone 
(DHT), androsterone, etiocholanolone, 
gestagen, a new undocumented 
designer steroid 
Nielen et al. 
2006 
26  AR-CALUX from 
BDS (stably 
Enzymatic deconjugation followed 
by LLE with methyl-tert-butylether 
Five males and five 
females provided urine 
samples 
These androgens were identified: 
Testosterone, DHT, epi-testosterone, 
Houtman et al. 
2009 
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transfected human 
U2OS cell line) 
epi-DHT, androsterone, 
etiocholanolone 
27 AR activity 
(agonism & 
antagonism) 
AR assay, transient 
transfected CHO 
cells with hAR and 
MMTV--LUC 
POPs were extracted from 3.6 ml serum 
samples by SPE using Oasis HLB 
cartridges followed by HPLC 
fractionation in order to obtain the 
fraction (F1) containing POP mixtures 
but free of endogenous hormones 
Adult male serum (n = 261) 
from Greenland, Sweden, 
Poland, and Ukraine 
The study groups differed significantly 
with respect to AR antagonistic activity, 
which was 
increased in the Inuits and decreased 
in the European study groups; No 
difference in AR agonistic activity was 
found. 
Krüger et al. 
2007 
28 AR activity 
(antagonism) 
PALM reporter 
gene assay 
1.0 g of placenta homogenates were 
extracted with acetonitrile. The 
supernatant was filtered and 
fractionated by preparative HPLC on a 
Spherisorb Si60 normal phase column. 
27 fraction were collected. 
29 male newborn cases 
with congenital 
malformations and 60 
healthy male controls were 
included from San Cecilio 
University Hospital, 
Granada, Spain 
The multivariable statistical analyses 
indicated a statistically significant 
positive association between the total 
effective xenobiotic burden of anti-
androgens (TEXB-AA) of the HPLC 
fraction collected during minutes 1–2 
(F2) and the risk of malformations 
(odds ratio: 2.33, 95% CI: 1.04–5.23). 
Arrebola et al. 
2015 
29 ER and AR MVLN assay (ER),  
AR assay, transient 
tranfections 
ER and AR assays: POPs were 
extracted from 3.6 mL serum samples 
by SPE using Oasis HLB cartridges 
followed by HPLC fractionation in order 
to obtain the fraction (F1) containing 
POP mixtures but free of endogenous 
hormones 
121 men and 119 women 
from  Greenland 
The xenohormone transactivities 
differed between districts as well as 
between genders. Associations 
between transactivities and age, n-3/n-
6 and smoker years were observed. 
The xenoestrogenic and 
xenoandrogenic transactivities 
correlated negatively to the POPs for 
the combined female and male data, 
respectively. 
Krüger et al. 
2008a 
30 ER & AhR DR-CALUX &  
ER-CALUX (human 
breast carcinoma 
T47D.Luc cell line 
stably 
transfected with 
pEREtataLuc 
construct) 
5 mL male serum were treated with 2 
mL methanol and extracted 3 times with 
n-hexane:diethyl ether (1:1); the 
extracts were evaporated and dissolved 
in 1 mL dichloro-methane. For 
determination of ER  activity, the solvent 
was replaced with DMSO in one-half of 
the crude extract; the second half of the 
sample was placed on a sulfuric acid-
activated silica column and eluted with 
150 individual male blood 
samples from residents of 
two areas of eastern 
Slovakia, which are 
differently contaminated 
with PCBs 
In human male serum samples, high 
levels of PCBs were associated with a 
decreased 
ER-mediated activity and an increased 
dioxin-like activity 
Pliskova et al. 
2005 
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n-hexane: diethylether mixture, 
evaporated, and redissolved in DMSO 
31 ER, AR & 
AhR 
MVLN assay (ER),  
AR assay 
(transiently 
transfected) &  
AhR assay 
(Denison) 
AhR assay:   
POPs were extracted at Le Centre de 
Toxicologie, CA as described under [6]. 
ER and AR assays: POPs were 
extracted from 3.6 mL serum as 
described under [17]. 
262 adult males (54 Inuits 
from Greenland, 69 from 
Poland, 81 from Sweden, 
and 58 from Ukraine  
Negative correlations between 
xenobiotic-induced receptor activities 
and sperm DNA damage were found 
for Inuits having relatively lower 
xenoestrogenic, lower dioxin-like 
activity, and lower sperm DNA damage, 
but higher xenoandrogenic activity. In 
the European groups, xenobiotic-
induced receptor activities were found 
to be positively correlated with the DNA 
damage. 
Long et al. 
2007 
32  MVLN assay (ER),  
AR assay 
(transiently 
transfected) &  
AhR assay 
(Denison) 
AhR assay:   
POPs were extracted at Le Centre de 
Toxicologie, CA as described under [6]. 
ER and AR assays: POPs were 
extracted from 3.6 ml serum as 
described under [17]. 
319 men from Warsaw 
(Poland), Greenland, 
Kharkiv (Ukraine), and 
Sweden 
No strong and consistent associations 
between xenobiotic activity and semen 
quality measures was observed in the 
four populations. However, when 
combining data across populations, 
some associations between ER activity 
and sperm parameters were found. 
Toft et al. 2007 
33  MVLN assay (ER),  
AR assay 
(transiently 
transfected) &  
AhR assay 
(Denison) 
AhR assay:   
POPs were extracted at Le Centre de 
Toxicologie, CA as described under [6]. 
ER and AR assays: POPs were 
extracted from 3.6 mL serum as 
described under [17]. 
The study included 53 
Greenlandic Inuits and 247 
Europeans (Sweden, 
Warsaw (Poland) and 
Kharkiv (Ukraine)). 
For Inuits, ER and AhR activities and 
DNA fragmentation were inversely 
correlated. For Europeans, a positive 
correlation between AR activity and 
DNA fragmentation was found. For 
Europeans correlations between ER 
and AR activities and DNA stainability 
was observed. 
Krüger et al. 
2008 
34  MVLN assay (ER),  
AR assay 
(transiently 
transfected) &  
AhR assay 
(Denison) 
AhR–CALUX assay: Dioxin-like POPs 
were extracted by SPE-Supelco using 2 
ml serum.  
ER and AR assays: POPs were 
extracted from 3.6 ml serum as 
described under [17]. 
31 Inuit breast cancer 
cases and 115 controls 
from Greenland 
Associations between breast cancer 
risk and AR agonistic activity were 
found. Cases elicited a higher 
frequency of ER agonistic activity, but a 
lower AhR activity. 
Bonefeld-
Jørgensen et 
al. 2011 
35  MVLN assay (ER),  AhR–CALUX assay: Dioxin-like POPs 
were extracted by SPE-Supelco using 2 
ml serum. 
232 Inuit samples from 
Greenland 
The transactivities correlated negatively 
to the POP levels and were associated 
to the lifestyle characteristics. 
Krüger et al. 
2012 
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AR assay 
(transiently 
transfected) &  
AhR assay 
(Denison) 
ER and AR assays: POPs were 
extracted from 3.6 ml serum as 
described under [17]. 
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